Pier 88 Investment Partners’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $525K | Sell |
3,820
-610
| -14% | -$83.9K | 0.1% | 87 |
|
|
2025
Q1 | $799K | Buy |
4,430
+680
| +18% | +$123K | 0.15% | 65 |
|
|
2024
Q4 | $587K | Buy |
3,750
+220
| +6% | +$34.5K | 0.12% | 69 |
|
|
2024
Q3 | $643K | Buy |
3,530
+170
| +5% | +$30.9K | 0.14% | 64 |
|
|
2024
Q2 | $617K | Buy |
3,360
+2,190
| +187% | +$402K | 0.14% | 74 |
|
|
2024
Q1 | $208K | Hold |
1,170
| – | – | 0.05% | 89 |
|
|
2023
Q4 | $145K | Buy |
+1,170
| New | +$145K | 0.04% | 86 |
|